In terms of FDA-approved prescription drugs for long-term weight loss treatment, there are currently six main options: Wegovy, Saxenda, Belviq, Contrave, Qsymia, and Xenical
The jury is still out on the long-term effects and results of GLP-1s, but early signs indicate stabilization for diabetic members with respect to cost and clinical outcomes
Managing your weight and understanding your caloric needs can be challenging, especially when youre taking GLP-1 medications such as Ozempic, Wegovy, Semaglutide, Mounjaro, Zepbound, Tirzepatide, Liraglutide, Saxenda, Trulicity, and Victoza
Partially used billing periods are generally non-refundable, though JRNYS may review requests at its discretion